50mg/mL Kanamycin Solution

Hazard statements (CLP)

H317, H334, H360

Code

Statements

H317

May cause an allergic skin reaction

SECTION 2: Hazards identification

(29 CFR 1910.1200) Classification of the substance or mixture

Hazard pictograms

GHS08

Hazard statements

H317 May cause an allergic skin reaction. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H360 May damage fertility or the unborn child.

Precautionary statements

P202 Do not handle until all safety precautions have been read and understood. P261 Avoid breathing dust/fume/gas/mist/vapors/spray. P272 Contaminated work clothing must not be allowed out of the workplace. P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/... P284 In case of inadequate ventilation wear respiratory protection. P302+P352 If on skin: Wash with plenty of water. P304+P340 If inhaled: Remove person to fresh air and keep comfortable for breathing. P308+P313 If exposed or concerned: Get medical advice/attention. P321 Specific treatment (see on this label). P333+P313 If skin irritation or rash occurs: Get medical advice/attention. P342+P311 If experiencing respiratory symptoms: Call a poison center/doctor. P362+P364 Take off contaminated clothing and wash it before reuse. P405 Store locked up. P501 Dispose of contents/container to industrial combustion plant.

Hazardous Ingredients

Kanamycin Sulfate

Results of PBT and vPvB assessment

Does not contain a PBT-/vPvB-substance at a concentration of ≥ 0.1%. Endocrine disrupting properties Does not contain an endocrine disruptor (ED) in a concentration of ≥ 0.1%.

2.1 Classification of the substance or mixture

Classification acc. to OSHA "Hazard Communication Standard" (29 CFR 1910.1200) Section Hazard class Category Hazard class and cat- Hazard state- egory ment A.4R respiratory sensitization 1 Resp. Sens. 1 H334 A.4S skin sensitization 1 Skin Sens. 1 H317 A.7 reproductive toxicity 1B Repr. 1B H360 For full text of abbreviations: see SECTION 16.